UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Annals of internal medicine, ISSN 0003-4819, 02/2017, Volume 166, Issue 3, pp. 191 - 200
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Hypoglycemic Agents - therapeutic use | Heart Failure - complications | Metformin - therapeutic use | Humans | Treatment Outcome | Renal Insufficiency, Chronic - complications | Cause of Death | Metformin - adverse effects | Contraindications | Liver Diseases - complications | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemia - chemically induced | Chronic Disease | Hypoglycemic Agents - adverse effects | Diabetes Mellitus, Type 2 - complications | Dosage and administration | Congestive heart failure | Metformin | Chronic kidney failure | Drug therapy | Heart failure | Patient safety | Prescription drugs | Liver diseases | Kidney diseases | Clinical outcomes | Index Medicus | Abridged Index Medicus
Journal Article
JAMA : the journal of the American Medical Association, ISSN 0098-7484, 02/2012, Volume 307, Issue 7, pp. 674 - 684
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Kidneys | Urinary system involvement in other diseases. Miscellaneous | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Glomerular Filtration Rate | Double-Blind Method | Hyperparathyroidism, Secondary - drug therapy | Vitamin D Deficiency - complications | Humans | Hypertrophy, Left Ventricular - etiology | Middle Aged | Ventricular Function, Left - drug effects | Vitamin D Deficiency - drug therapy | Ergocalciferols - therapeutic use | Male | Treatment Outcome | Hypercalcemia - chemically induced | Parathyroid Hormone - blood | Vitamins - therapeutic use | Vitamins - pharmacology | Ergocalciferols - pharmacology | Female | Aged | Kidney Diseases - complications | Hypertrophy, Left Ventricular - drug therapy | Vitamin D Deficiency - etiology | Chronic Disease | Clinical trials | Kidney diseases | Vitamin D | Drug therapy | Patients | Index Medicus | Abridged Index Medicus
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 08/2008, Volume 52, Issue 7, pp. 501 - 511
heart failure | chronic kidney disease | anemia | erythropoietin | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Cardiology. Vascular system | Heart | Hematologic and hematopoietic diseases | Anemias. Hemoglobinopathies | Diseases of red blood cells | Biological and medical sciences | Medical sciences | Heart failure, cardiogenic pulmonary edema, cardiac enlargement | Kidney Failure, Chronic - physiopathology | Heart Failure - complications | Humans | Risk Factors | Heart Failure - physiopathology | Male | Heart Failure - metabolism | Biomarkers - blood | Kidney Failure, Chronic - metabolism | Anemia - physiopathology | Anemia - metabolism | Anemia - drug therapy | Bone Marrow - metabolism | Kidney Failure, Chronic - complications | Female | Receptors, Erythropoietin - drug effects | Iron Compounds - therapeutic use | Erythropoietin - biosynthesis | Anemia - etiology | Inflammation - physiopathology | Heart failure | Disease | Cytokines | Anemia | Pulmonary arteries | Mortality | Clinical trials | Quality of life | Studies | Confidence intervals | Bone marrow | Hypoxia | Chronic illnesses | Index Medicus | Abridged Index Medicus
Journal Article
Nature reviews cardiology, ISSN 1759-5002, 03/2015, Volume 12, Issue 3, pp. 184 - 192
HIGH-DOSE FUROSEMIDE | CONVERTING ENZYME-INHIBITOR | PERMUTATION TRIAL TESTS | NEUROHORMONAL ACTIVATION | HYPERTONIC SALINE SOLUTION | BLOOD UREA NITROGEN | NATRIURETIC EFFECT ADDITION | RENAL-FUNCTION | CHRONIC KIDNEY-DISEASE | LONG-TERM TREATMENT | Cardiac & Cardiovascular Systems | Life Sciences & Biomedicine | Cardiovascular System & Cardiology | Science & Technology | Acute Disease | Sodium Potassium Chloride Symporter Inhibitors - therapeutic use | Humans | Heart Failure - physiopathology | Treatment Outcome | Drug Therapy, Combination | Drug Resistance | Heart Failure - drug therapy | Heart failure | Diuretics | Care and treatment | Patient outcomes | Index Medicus
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2011, Volume 377, Issue 9784, pp. 2181 - 2192
Internal Medicine | UNITED-KINGDOM HEART | DESIGN | METAANALYSIS | REQUIRING PROLONGED OBSERVATION | EFFICACY | CARDIOVASCULAR EVENTS | SAFETY | HEMODIALYSIS | OUTCOMES | UMCG Approved | PARTICIPANTS | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Kidneys | Urinary system involvement in other diseases. Miscellaneous | Nephropathies. Renovascular diseases. Renal failure | Renal failure | Nephrology. Urinary tract diseases | Biological and medical sciences | Medical sciences | Confidence Intervals | Simvastatin - adverse effects | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Ezetimibe | Renal Dialysis - methods | Male | Reference Values | Cholesterol, LDL - analysis | Kidney Function Tests | Renal Insufficiency, Chronic - drug therapy | Dose-Response Relationship, Drug | Renal Insufficiency, Chronic - therapy | Renal Dialysis - mortality | Time Factors | Renal Insufficiency, Chronic - mortality | Adult | Female | Renal Insufficiency, Chronic - diagnosis | Drug Therapy, Combination | Severity of Illness Index | Hypolipidemic Agents - adverse effects | Double-Blind Method | Drug Administration Schedule | Risk Assessment | Simvastatin - administration & dosage | Cholesterol, LDL - drug effects | Treatment Outcome | Azetidines - administration & dosage | Hypolipidemic Agents - administration & dosage | Survival Analysis | Aged | Simvastatin | Low density lipoproteins | Physiological aspects | Drug therapy, Combination | Research | Kidney diseases | Diagnosis | Drug therapy | Health aspects | Studies | Heart failure | Cardiac arrhythmia | Medical imaging | Hospitals | Compliance | Cardiovascular disease | Blood pressure | Family medical history | Cholesterol | Cancer | Index Medicus | Abridged Index Medicus | Mortality | myocardial infarction | cholesterol | councils | Dialysis | medical research | stroke | Kidney | Fast track
Journal Article
BMJ : British Medical Journal, ISSN 0959-8138, 3/2015, Volume 350, Issue mar11 2, pp. 1 - 8
RESEARCH | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Comorbidity | Humans | Depressive Disorder - drug therapy | United Kingdom | Antidepressive Agents | Contraindications | Diabetes Mellitus, Type 2 - epidemiology | Heart Failure - drug therapy | Renal Insufficiency, Chronic - epidemiology | Hypoglycemic Agents | Drug Interactions | Depressive Disorder - epidemiology | Hypertension - epidemiology | Diabetes Mellitus, Type 2 - drug therapy | Heart Failure - epidemiology | Practice Guidelines as Topic | Index Medicus | Abridged Index Medicus
Journal Article
JAMA internal medicine, ISSN 2168-6106, 10/2016, Volume 176, Issue 10, pp. 1443 - 1450
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Folic Acid - therapeutic use | Glomerular Filtration Rate | Double-Blind Method | Vitamin B Complex - therapeutic use | Humans | Kidney Failure, Chronic - drug therapy | Middle Aged | Homocysteine - blood | Hypertension - drug therapy | Male | Enalapril - therapeutic use | Disease Progression | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | China | Folic Acid - blood | Female | Aged | Drug Combinations | Care and treatment | Usage | Adults | Chronic kidney failure | Health aspects | Folic acid | Index Medicus | Abridged Index Medicus
Journal Article